Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
about
Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestryRacial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.Triple-negative breast cancer in African-American women: disparities versus biology.Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.Does race affect outcomes in triple negative breast cancer?Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis.Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial.Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review.Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scaleEffect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancerRace, response to chemotherapy, and outcome within clinical breast cancer subtypes.Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.Racial differences in outcomes of triple-negative breast cancerOutcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkMorphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational studyFailure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women.Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.Adjuvant therapy of triple negative breast cancer.The geographic distribution of mammography resources in Mississippi.The paradox of triple negative breast cancer: novel approaches to treatment.PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages.Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group ExperienceAfrican American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology.The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer.The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study
P2860
Q27011535-38034583-2BEF-4D71-8C75-0694147DD8CDQ30823443-63A67607-1ECA-4CE4-A8BA-BC9065F92E49Q33797203-5CADCF0F-E9E1-4498-B3F1-CB2264FB8AEEQ33813431-BC8D082D-39B3-457A-B479-20C2AF068EF8Q34037589-FDF7067E-C4EE-490B-BAC4-F9BF2E240A28Q34197501-BBA432B9-D342-4F43-B765-A73B7C42CDDCQ34273563-6A555E5D-30DB-4A2B-A407-050275604DD6Q34480023-0F2CA2EE-6853-4699-986C-CA319B425426Q34613569-944EAB5D-C850-4329-8645-C5360F987B73Q35059135-033DA5AD-F2A8-44CD-AF30-4912EA69D686Q35144499-2FC98F3C-917A-4D16-8EF7-352F0F8BFA2EQ35511314-7CD0D3D1-39ED-4229-A990-D1487A0567B3Q35568229-A59CFFF9-4F89-4191-B23D-4E2D3A70CC13Q35584078-84F4830A-BFF6-42BE-B48D-62513AB82DA4Q35956986-E4AF4BEB-F95B-4FED-B84D-AFA5D3420556Q35974918-5709A8DC-9EFD-4591-87AB-115A0E31377CQ36343773-8EDD06BA-21B7-4B80-B4F0-5BEBB6FDBD7AQ36726996-B854B416-8661-419E-8BFC-BFA154A989EEQ36868191-9599A244-1959-4A0D-AFE8-3B4BBB8D77C8Q37017435-B4D5C3B0-29D3-4ECB-8ACF-6C475CD06EF4Q37191364-0DDE3885-DC9F-4C28-A4F6-7CE04B551DE4Q37269261-8D9A522D-F997-446E-82BC-9932CE380C6DQ37571648-C834F954-C014-4B68-B23A-C0413C0DE172Q37649303-D45BD6A7-BBE0-46FB-BAF0-D96352CF78C8Q37958063-6D0366EE-C83F-4A0E-9388-EA27E54C51FFQ39002862-E091F57E-438B-4023-923A-55017A7A0954Q39132868-FE77064C-78D3-44A4-B84A-25DD6B3AD8B1Q40063848-F1732124-5C72-4453-817D-1CD97708958CQ41701909-A996EBC8-B72B-467D-B963-CB077F69061EQ41839791-E75067E2-7D17-4035-91BA-0F0596830C36Q42926176-4E161F6C-AF73-432B-B503-5B7393A8F27DQ44462595-39E2521F-4BE3-4E93-9865-F171E51140F2Q45899064-67C3D1F9-FA77-4267-B4E7-AD92853EA822Q46759303-8E408BBE-A4A5-4315-94A7-054F9B16CF07Q47215852-6F485A79-1BA6-487F-8C9C-8DE833BD5671Q49166198-22563015-88EE-4A15-BA3D-BFE382D4A643Q52561252-89B2720B-4C31-44B9-9F2A-937318CE0FAFQ58804580-AD8B3407-87B7-4482-A411-DF0A46954DA3
P2860
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Triple receptor-negative breas ...... eatment and survival outcomes.
@ast
Triple receptor-negative breas ...... eatment and survival outcomes.
@en
type
label
Triple receptor-negative breas ...... eatment and survival outcomes.
@ast
Triple receptor-negative breas ...... eatment and survival outcomes.
@en
prefLabel
Triple receptor-negative breas ...... eatment and survival outcomes.
@ast
Triple receptor-negative breas ...... eatment and survival outcomes.
@en
P2093
P2860
P356
P1476
Triple receptor-negative breas ...... eatment and survival outcomes.
@en
P2093
Ana Maria Gonzalez-Angulo
Bryan T J Hennessy
Constance Albarracin
Gabriel N Hortobagyi
Kristine Broglio
Marjorie C Green
Shaheenah Dawood
Shu-Wan Kau
Thomas A Buchholz
Wei T Yang
P2860
P304
P356
10.1200/JCO.2008.17.9952
P407
P577
2008-12-01T00:00:00Z